Clinical Cancer Research The Science of Cancer Health Disparities Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang-Johanning, F.
Right arrow Articles by Strong, T. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang-Johanning, F.
Right arrow Articles by Strong, T. V.
Clinical Cancer Research Vol. 7, 1553-1560, June 2001
© 2001 American Association for Cancer Research


Advances in Brief

Expression of Human Endogenous Retrovirus K Envelope Transcripts in Human Breast Cancer1

Feng Wang-Johanning, Andra R. Frost, Gary L. Johanning, M. B. Khazaeli, Albert F. LoBuglio, Denise R. Shaw and Theresa V. Strong2

The Comprehensive Cancer Center and Division of Hematology Oncology, Departments of Medicine [F. W-J., M. B. K., A. F. L., D. R. S., T. V. S.], Pathology [A. R. F.], and Nutrition Sciences [G. L. J.], University of Alabama at Birmingham, Birmingham, Alabama 35294-3300

Purpose: We investigated the expression of human endogenous retroviral (HERV) sequences in breast cancer.

Experimental Design: Reverse transcription-PCR (RT-PCR) was used to examine expression of the envelope (env) region of ERV3, HERV-E4-1, and HERV-K in breast cancer cell lines, human breast tumor samples, adjacent uninvolved breast tissues, nonmalignant breast tissues, and placenta. Expression of HERV transcripts was confirmed by Northern blot analysis and in situ hybridization (ISH). To evaluate coding potential, amplified HERV sequences were cloned into vectors for expression and sequence analysis.

Results: No expression of ERV3 or HERV-E4-1 RNA was detected in the analyzed breast samples. In contrast, HERV-K transcripts were detected in most breast cancer cell lines and many breast tumor tissues. Expression was detected in a small percentage of matched, uninvolved breast tissues and in placentas but not nonmalignant breast tissues. In HERV-K-positive breast cancer tissues, Northern blot analysis demonstrated full-length proviral and spliced env transcripts. ISH demonstrated expression of HERV-K transcripts in breast tumor cells but not in normal or uninvolved breast epithelial cells. Independently isolated clones of HERV-K env cDNA generated recombinant proteins of the expected size. Sequence analysis of env cDNA clones derived from four breast tumor samples revealed >97% identity with the type I HERV-K102, with no premature termination codons. Independent isolates from the same breast tumor sample showed nucleotide sequence differences, suggesting that multiple loci may be transcribed.

Conclusions: These data indicate that HERV-K transcripts with coding potential for the envelope region are expressed frequently in human breast cancer.




This article has been cited by other articles:


Home page
Cancer Res.Home page
F. Wang-Johanning, L. Radvanyi, K. Rycaj, J. B. Plummer, P. Yan, K. J. Sastry, C. J. Piyathilake, K. K. Hunt, and G. L. Johanning
Human Endogenous Retrovirus K Triggers an Antigen-Specific Immune Response in Breast Cancer Patients
Cancer Res., July 15, 2008; 68(14): 5869 - 5877.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
C. Voisset, R. A. Weiss, and D. J. Griffiths
Human RNA "Rumor" Viruses: the Search for Novel Human Retroviruses in Chronic Disease
Microbiol. Mol. Biol. Rev., March 1, 2008; 72(1): 157 - 196.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
O. Frank, C. Verbeke, N. Schwarz, J. Mayer, A. Fabarius, R. Hehlmann, C. Leib-Mosch, and W. Seifarth
Variable Transcriptional Activity of Endogenous Retroviruses in Human Breast Cancer
J. Virol., February 15, 2008; 82(4): 1808 - 1818.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. Seifarth, O. Frank, U. Zeilfelder, B. Spiess, A. D. Greenwood, R. Hehlmann, and C. Leib-Mosch
Comprehensive Analysis of Human Endogenous Retrovirus Transcriptional Activity in Human Tissues with a Retrovirus-Specific Microarray
J. Virol., January 1, 2005; 79(1): 341 - 352.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Bannert and R. Kurth
Retroelements and the human genome: New perspectives on an old relation
PNAS, October 5, 2004; 101(suppl_2): 14572 - 14579.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Armbruester, M. Sauter, K. Roemer, B. Best, S. Hahn, A. Nty, A. Schmid, S. Philipp, A. Mueller, and N. Mueller-Lantzsch
Np9 Protein of Human Endogenous Retrovirus K Interacts with Ligand of Numb Protein X
J. Virol., October 1, 2004; 78(19): 10310 - 10319.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
J.-M. Yi, H.-M. Kim, and H.-S. Kim
Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells
J. Gen. Virol., May 1, 2004; 85(5): 1203 - 1210.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Bronte, S. Cingarlini, E. Apolloni, P. Serafini, I. Marigo, C. De Santo, B. Macino, O. Marin, and P. Zanovello
Effective Genetic Vaccination with a Widely Shared Endogenous Retroviral Tumor Antigen Requires CD40 Stimulation during Tumor Rejection Phase
J. Immunol., December 15, 2003; 171(12): 6396 - 6405.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Rosato, S. D. Santa, A. Zoso, S. Giacomelli, G. Milan, B. Macino, V. Tosello, P. Dellabona, P.-L. Lollini, C. De Giovanni, et al.
The Cytotoxic T-Lymphocyte Response against a Poorly Immunogenic Mammary Adenocarcinoma Is Focused on a Single Immunodominant Class I Epitope Derived from the gp70 Env Product of an Endogenous Retrovirus
Cancer Res., May 1, 2003; 63(9): 2158 - 2163.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Schiavetti, J. Thonnard, D. Colau, T. Boon, and P. G. Coulie
A Human Endogenous Retroviral Sequence Encoding an Antigen Recognized on Melanoma by Cytolytic T Lymphocytes
Cancer Res., October 1, 2002; 62(19): 5510 - 5516.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Armbruester, M. Sauter, E. Krautkraemer, E. Meese, A. Kleiman, B. Best, K. Roemer, and N. Mueller-Lantzsch
A Novel Gene from the Human Endogenous Retrovirus K Expressed in Transformed Cells
Clin. Cancer Res., June 1, 2002; 8(6): 1800 - 1807.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.